These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 286848)

  • 21. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prognostic value of measuring cell size in acute childhood leukemia (author's transl)].
    Scheer U; Schellong G
    Klin Padiatr; 1979 Mar; 191(2):127-32. PubMed ID: 286843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group.
    Creutzig U; Ritter J; Schellong G
    Blood; 1990 May; 75(10):1932-40. PubMed ID: 2186819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of the cytochemical classification of acute leukemia in children with the course of their disease (author's transl)].
    Steilner B; Pfister S; Bömer H; Drees N; Sieron G
    Monatsschr Kinderheilkd (1902); 1977 Dec; 125(12):959-65. PubMed ID: 271764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland.
    Balwierz W; Pawinska-Wasikowska K; Klekawka T; Czogala M; Matysiak M; Fic-Sikorska B; Adamkiewicz-Drozynska E; Maciejka-Kapuscinska L; Chybicka A; Potocka K; Wachowiak J; Skalska-Sadowska J; Kowalczyk J; Wojcik B; Wysocki M; Koltan S; Krawczuk-Rybak M; Muszynska-Roslan K; Mlynarski W; Stolarska M; Urasinski T; Kamienska E; Szczepanski T; Tomaszewska R; Sobol G; Mizia-Malarz A; Karolczyk G; Podhorecka J; Wieczorek M; Karpinska-Derda I; Badowska W; Moryl-Bujakowska A
    Memo; 2013 Feb; 6(1):54-62. PubMed ID: 23565126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Apoplexies in children; a case of multiple bleeding into the white substance in acute myelogenous leucemia].
    VOLLAND W
    Dtsch Z Nervenheilkd; 1952; 168(5):418-26. PubMed ID: 12988921
    [No Abstract]   [Full Text] [Related]  

  • 27. Relapsed Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Center in Thailand.
    Songthawee N; Sripornsawan P; Chavananon S; McNeil EB; Chotsampancharoen T
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4079-4084. PubMed ID: 36579988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute monocytic leukemia complicating combined-modality therapy for localized childhood Ewing's sarcoma.
    Schmitt-Gräff A; Jürgens H; Göbel U; Ritter J; Lübbesmeier A; Borchard F
    J Cancer Res Clin Oncol; 1981; 102(1):93-7. PubMed ID: 6949907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute myelogenous leukemia in children.
    Schellong G; Creutzig U; Ritter J
    Med Oncol Tumor Pharmacother; 1985; 2(1):17-25. PubMed ID: 3863999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aseptic osteonecroses in the treatment of childhood acute leukaemias.
    Bömelburg T; von Lengerke HJ; Ritter J
    Eur J Pediatr; 1989 Oct; 149(1):20-3. PubMed ID: 2606123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognosis improvements in children with acute myelocytic leucemia after more intensive induction therapy (author's transl)].
    Scheer U; Schellong G; Riehm H
    Klin Padiatr; 1979 Mar; 191(2):210-6. PubMed ID: 286848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years].
    Creutzig U; Ritter J; Langermann HJ; Riehm H; Henze G; Niethammer D; Jürgens H; Stollmann B; Lasson U; Kabisch H; Wahlen W; Löffler H; Schellong G
    Klin Padiatr; 1983; 195(3):152-60. PubMed ID: 6576202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93].
    Creutzig U; Zimmermann M; Reinhardt D; Lehrnbecher T
    Klin Padiatr; 2003; 215(3):151-8. PubMed ID: 12778355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
    Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.